
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SLUG CRISPR/Cas9 KO Plasmid (m) | sc-423024 | 20 µg | $397.00 | |||
SLUG HDR Plasmid (m) | sc-423024-HDR | 20 µg | $445.00 |
Snai2 encodes the zinc-finger transcription factor SLUG, a key regulator of epithelial–mesenchymal transition (EMT) that represses epithelial gene programs such as E-cadherin and coordinates lineage plasticity. In mouse cells, SLUG integrates signals from pathways including TGF-β, Wnt/β-catenin, Notch, and receptor tyrosine kinases to control migration, invasion-related transcriptional states, and survival under stress. It contributes to developmental processes such as neural crest and mesenchymal differentiation and modulates stem/progenitor cell behavior in multiple tissues. Dysregulated SNAI2/SLUG activity is frequently associated with EMT-linked phenotypes in cancer biology, fibrosis, and inflammation-related remodeling, making it a widely used node for mechanistic studies of transcriptional reprogramming.
SLUG CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Snai2 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Snai2 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, SLUG HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Snai2 target site.
When co-transfected with SLUG CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Snai2 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.